Trial to Assess Optimized Dosage of Lacosamide as add-on Therapy in Patients With Partial Onset Seizure

PHASE4CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

June 30, 2010

Primary Completion Date

December 31, 2011

Study Completion Date

December 31, 2011

Conditions
Partial Epilepsies
Interventions
DRUG

Lacosamide

"Lacosamide : 50 mg tablets bid. Titration phase: (12 weeks) 100 mg/day: duration 1 to 3 weeks. Then uptitration to optimal therapeutic dose of 200 mg/day to 400 mg/day, in steps of 100 mg/day and a time period per step of 1 to 3 weeks.~Maintenance phase (12 weeks): Optimal therapeutic dose 200 mg/day to 400 mg/day.~Taper phase if needed: 3 to 4 weeks"

Trial Locations (32)

Unknown

Amiens

Aubenas

Auxerre

Bordeaux

Brest

Caen

Carpentras

Châteaubriand

Colmar

Créteil

Gap

Gonesse

La Rochelle

Laval

Limoges

Marseille

Montluçon

Nice

Nîmes

Paris

Perpignan

Poitiers

Pringy

Rennes

Rouen

Saint Aubin Sur Cie

Saint Julien En Gengvois

Saint-Brieuc

St-Malo

Toulouse

Vienne

Villeurbanne

Sponsors

Lead Sponsor

All Listed Sponsors
lead

UCB Pharma

INDUSTRY